Unlocking Radiomics for Nasopharyngeal Carcinoma (NPC) Nasopharyngeal carcinoma (NPC) is a highly aggressive cancer often diagnosed at locally advanced stages. In recent years, immune checkpoint inhibitors (such as PD-1 blockers) have offered new hope, yet most patients derive only limited durable benefit. A multicenter study led by researchers from the First Affiliated Hospital of Jinan…